{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:31:50Z","timestamp":1760646710883,"version":"3.40.5"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004482","name":"Animal Resource Center, Health Science Center, Kuwait University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004482","id-type":"DOI","asserted-by":"publisher"}]},{"name":"RCF\/OMICSRU"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.neuropharm.2017.10.020","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T07:19:28Z","timestamp":1508224768000},"page":"231-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Monoamine oxidase-B inhibitor protects degenerating spinal neurons, enhances nerve regeneration and functional recovery in sciatic nerve crush injury model"],"prefix":"10.1016","volume":"128","author":[{"given":"Al-Shimali M.","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9024-9712","authenticated-orcid":false,"given":"Waleed M.","family":"Renno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaa L.","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noura M.","family":"Kayali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aseel","family":"Al-Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muddanna S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.10.020_bib1","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1523\/JNEUROSCI.13-09-04042.1993","article-title":"Rescue of axotomized immature rat facial motoneurons by R (\u2013)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition","volume":"13","author":"Ansari","year":"1993","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib3","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.85.13.4934","article-title":"cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties","volume":"85","author":"Bach","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib4","first-page":"313","article-title":"Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?","volume":"32","author":"Baker","year":"2007","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib5","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.neurobiolaging.2014.10.026","article-title":"Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A\/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging","volume":"36","author":"Bar-Am","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0161-813X(03)00094-9","article-title":"Monoamine oxidase (MAO) in human peripheral tissues","volume":"25","author":"Billett","year":"2004","journal-title":"Neurotoxicol"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jns.2016.08.028","article-title":"Bradykinesia in early and advanced Parkinson's disease","volume":"369","author":"Bologna","year":"2016","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/02713689508999923","article-title":"(-)-Deprenyl increases the survival of rat retinal ganglion cells after optic nerve crush","volume":"14","author":"Buys","year":"1995","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib9","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3892\/mmr.2014.2040","article-title":"Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease","volume":"9","author":"Cai","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijdevneu.2008.07.005","article-title":"Prenatal exposure to a non-steroidal anti-inflammatory drug or saline solution impairs sciatic nerve morphology: a stereological and histological study","volume":"26","author":"Canan","year":"2008","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2990.2008.00938.x","article-title":"An efficient stereological sampling approach for quantitative assessment of nerve regeneration","volume":"34","author":"Canan","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejphar.2015.07.015","article-title":"Neuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against A\u03b2(1-42)-induced toxicity","volume":"764","author":"Caraci","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib13","first-page":"1254","article-title":"Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3- year retrospective case-control study","volume":"264","author":"Cereda","year":"2017","journal-title":"J.\u00a0Neural"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/jbt.21722","article-title":"Immunocytochemical localization of monoamine oxidase type B in Rat's peripheral nervous system","volume":"29","author":"Chen","year":"2015","journal-title":"J.\u00a0Biochem. Mol. Toxicol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2013.11.014","article-title":"Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease","volume":"79","author":"Chiu","year":"2014","journal-title":"Neuropharm"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2004.03.051","article-title":"Pharmacological characterization of the chronic constriction injury model of neuropathic pain","volume":"491","author":"De Vry","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib17","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1073\/pnas.111027698","article-title":"Pro-apoptotic gene expression mediated by the p38 mitogen-activated protein kinase signal transduction pathway","volume":"98","author":"De Zutter","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/1871527316666170124165222","article-title":"Monoamine oxidase B inhibitors in Parkinson's disease","volume":"16","author":"Dezsi","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuropharm.2016.01.024","article-title":"Binge ethanol exposure increases the Kr\u00fcppel-like factor 11-monoamine oxidase (MAO) pathway in rats: examining the use of MAO inhibitors to prevent ethanol-induced brain injury","volume":"105","author":"Duncan","year":"2016","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/glia.440080208","article-title":"Monoamine oxidase-B in astrocytes","volume":"8","author":"Ekblom","year":"1993","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib21","first-page":"253","article-title":"Reactive gliosis and monoamine oxidase B","volume":"41","author":"Ekblom","year":"1994","journal-title":"J.\u00a0Neural. Transm. Suppl."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fphar.2016.00340","article-title":"Inhibitors of MAO-a and MAO-B in psychiatry and neurology","volume":"7","author":"Finberg","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib23","first-page":"1331","article-title":"PET imaging of monoamine oxidase B in peripheral organs in humans","volume":"43","author":"Fowler","year":"2002","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1806-83242004000200002","article-title":"Evaluation of the Image-Pro Plus 4.5 software for automatic counting of labeled nuclei by PCNA immunohistochemistry","volume":"18","author":"Francisco","year":"2004","journal-title":"Braz. Oral Res."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib25","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1212\/WNL.50.3.660","article-title":"L-Deprenyl in Alzheimer's disease. Cognitive and behavioral effects","volume":"50","author":"Freedman","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.phrs.2006.04.008","article-title":"Role of catecholamines and serotonin receptor subtypes in nefopam-induced antinociception","volume":"54","author":"Girard","year":"2006","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib27","first-page":"974013","article-title":"Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress","author":"Goverdhan","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1476-5381.1975.tb06946.x","article-title":"Effects of monoamine oxidase inhibition by clorgyline, deprenyl or tranycypromine on 5-hydroxy-tryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration","volume":"55","author":"Green","year":"1975","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib29","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1073\/pnas.88.9.3637","article-title":"Human monoamine oxidase A and B genes exhibit identical exon-intron organization","volume":"88","author":"Grimsby","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-017-1740-9","article-title":"Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline","author":"Inaba-Hasegawa","year":"2017","journal-title":"J.\u00a0Neural Transm. (Vienna)"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib31","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/0006-2952(68)90066-X","article-title":"Some observations upon a new inhibitor of monoamine oxidase in brain tissue","volume":"17","author":"Johnston","year":"1968","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF01255819","article-title":"Localization of monoamine oxidase B in human brain by autoradiographical use of 11C-labelled L-deprenyl","volume":"77","author":"Jossan","year":"1989","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib33","first-page":"243","article-title":"Monoamine oxidase-B in motor cortex and spinal cord in amyotrophic lateral sclerosis studied by quantitative autoradiography","volume":"41","author":"Jossan","year":"1994","journal-title":"J.\u00a0Neural Transm. Suppl."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jneumeth.2005.02.012","article-title":"A\u00a0simple technique for localizing consecutive fields for dissector pairs in light microscopy: application to neuron counting in rabbit spinal cord following spinal cord injury","volume":"145","author":"Kaplan","year":"2005","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib35","article-title":"Quinolinic carboxylic acid derivatives as potential multi-target compounds for neurodegeneration: monoamine oxidase and cholinesterase inhibition","author":"Khan","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib36","first-page":"179","article-title":"(\u2013)Deprenyl (Selegiline): past, present and future","volume":"8","author":"Knoll","year":"2000","journal-title":"Neurobiol. (Bp.)"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib37","first-page":"431","article-title":"Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease","volume":"8","author":"Kong","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneumeth.2009.12.020","article-title":"TTC staining of damaged brain areas after MCA occlusion in the rat does not constrict quantitative gene and protein analyses","volume":"187","author":"Kramer","year":"2010","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/jpet.109.156034","article-title":"Thermal hyperalgesia via supraspinal mechanisms in mice lacking glutamate decarboxylase 65","volume":"331","author":"Kubo","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib40","first-page":"289","article-title":"The neuroprotective effect of antidepressant drug via inhibition of TIEG2-MAO B mediated cell death","volume":"2","author":"Lu","year":"2008","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneumeth.2007.02.017","article-title":"Long-term functional and morphological assessment of a standardized rat sciatic nerve crush injury with a non-serrated clamp","volume":"163","author":"Lu\u00eds","year":"2007","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/cne.903630410","article-title":"Cellular expression of mRNAs encoding monoamine oxidases A and B in the rat central nervous system","volume":"363","author":"Luque","year":"1995","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0161-813X(03)00102-5","article-title":"(\u2212)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties","volume":"25","author":"Magyar","year":"2004","journal-title":"Neurotoxicol"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01249088","article-title":"Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington's disease compared to schizophrenics and controls","volume":"65","author":"Mann","year":"1986","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0047-6374(99)00066-4","article-title":"Neuroprotection by (\u2212)-deprenyl and related compounds","volume":"111","author":"Maruyama","year":"1999","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0165-0270(03)00207-3","article-title":"Directly applied low intensity direct electric current enhances peripheral nerve regeneration in rats","volume":"129","author":"Mendonca","year":"2003","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneumeth.2011.10.011","article-title":"A\u00a0transgenic rat expressing green fluorescent protein (GFP) in peripheral nerves provides a new hindlimb model for the study of nerve injury and regeneration","volume":"204","author":"Moore","year":"2012","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib49","first-page":"53","article-title":"Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells","volume":"71","author":"Nagatsu","year":"2006","journal-title":"J.\u00a0neural Transm."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib50","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1586\/ern.13.60","article-title":"Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms","volume":"13","author":"Naoi","year":"2013","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib51","doi-asserted-by":"crossref","first-page":"10923","DOI":"10.1073\/pnas.0601515103","article-title":"Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway","volume":"103","author":"Ou","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10284150600576705","article-title":"Green tea pain modulating effect in sciatic nerve chronic constriction injury rat model","volume":"9","author":"Renno","year":"2006","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib54","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00210-012-0758-7","article-title":"(-)-Epigallocatechin-3-gallate (EGCG) attenuates functional deficits and morphological alterations by diminishing apoptotic gene overexpression in skeletal muscles after sciatic nerve crush injury","volume":"385","author":"Renno","year":"2012","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib55","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuint.2012.12.018","article-title":"(-)-Epigallocatechin-3-gallate (EGCG) attenuates peripheral nerve degeneration in rat sciatic nerve crush injury","volume":"62","author":"Renno","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuropharm.2013.09.013","article-title":"(-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats","volume":"77","author":"Renno","year":"2014","journal-title":"Neuropharm"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/neu.2014.3491","article-title":"(-)-Epigallocatechin-3-gallate modulates spinal cord neuronal degeneration by enhancing growth-associated protein 43, B-cell lymphoma 2, and decreasing B-cell lymphoma 2-associated x protein expression after sciatic nerve crush injury","volume":"32","author":"Renno","year":"2015","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2015.10.029","article-title":"Is there a role for neurotrophic factors and their receptors in augmenting the neuroprotective effect of (-)-epigallocatechin-3-gallate treatment of sciatic nerve crush injury?","volume":"102","author":"Renno","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib59","first-page":"1","article-title":"A\u00a0possible role of Anti-oxidative capacity of (-)-epigallocatechin-3-gallate treatment on morphological and neurobehavioral recovery of sciatic nerve crush","volume":"4","author":"Renno","year":"2017","journal-title":"J.\u00a0Neurosurg. Spine"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib60","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-7091-6499-0_17","article-title":"Monoamine oxidases: from brain maps to physiology and transgenics to pathophysiology","volume":"52","author":"Richards","year":"1998","journal-title":"J.\u00a0Neural Transm. Suppl."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/17425255.2017.1273901","article-title":"Use of monoamine oxidase inhibitors in chronic neurodegeneration","volume":"13","author":"Riederer","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40263-015-0249-8","article-title":"Defining the role of the monoamine Oxidase-B inhibitors for Parkinson's disease","volume":"29","author":"Robakis","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib92","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s004010050453","article-title":"Monoamine oxidase B inhibitor selegiline protects young and aged rat peripheral sympathetic neurons against 6-hydroxydopamine-induced neurotoxicity","volume":"91","author":"Salonen","year":"1996","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib63","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A\u00a0controlled trial of Selegiline, alpha tocopherol or both as treatment for Alzheimer's disease","volume":"336","author":"Sano","year":"1997","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib64","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneumeth.2014.01.020","article-title":"Sciatic nerve injury: a simple and subtle model for investigating many aspects of nervous system damage and recovery","volume":"227C","author":"Savastano","year":"2014","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00343762","article-title":"Monoamine oxidase activity in brain regions and organs of patients with Parkinson's disease and Huntington's disease and serum MAO activity of patients with Huntington's disease as compared with neurologically healthy individuals (author's transl)","volume":"230","author":"Schneider","year":"1981","journal-title":"Arch. Psychiatr. Nervenkr"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib66","first-page":"333","article-title":"The association of monoamine oxidase B functional polymorphism with postoperative pain intensity","volume":"27","author":"Sery","year":"2006","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib67","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/11596310-000000000-00000","article-title":"Monoamine oxidase B inhibitors fort the treatment of Parkinson's disease: a review of symptomatic and potential disease-modifying effects","volume":"25","author":"Shapiro","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib68","first-page":"1","article-title":"Molecular basis of human MAO-A and MAO-B","volume":"4","author":"Shih","year":"1991","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib69","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","article-title":"Monoamine oxidase: from genes to behavior","volume":"22","author":"Shih","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib70","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1570159043476800","article-title":"Amine oxidase inhibitors and development of neuroprotective drugs","volume":"2","author":"Sowa","year":"2004","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib71","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00702-002-0827-z","article-title":"Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B","volume":"110","author":"Tatton","year":"2003","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib72","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1046\/j.1471-4159.1994.63041572.x","article-title":"(\u2212)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis","volume":"63","author":"Tatton","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib73","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00000542-199504000-00026","article-title":"Neurologic evaluation of the rat during sciatic nerve block with lidocaine","volume":"82","author":"Thalhammer","year":"1995","journal-title":"Anesthesiol"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib74","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0197-4580(00)00100-7","article-title":"Monoamine oxidase-B inhibitors in the treatment of Alzheimer's disease","volume":"21","author":"Thomas","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib75","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1742-1241.2007.01433.x","article-title":"Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine","volume":"61","author":"Thor","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib76","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2174\/0929867043364810","article-title":"Monoamine oxidases: certainties and uncertainties","volume":"11","author":"Tipton","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib77","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1018508819191","article-title":"Diphenylpiperazines enhance regeneration after facial nerve injury","volume":"26","author":"Tong","year":"1997","journal-title":"J.\u00a0Neurocytol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib78","first-page":"10","article-title":"Stereological analysis of sciatic nerve in chickens following neonatal pinealectomy: an experimental study","volume":"5","author":"Turgut","year":"2010","journal-title":"J.\u00a0Brachial Plex. Peripher Nerve Inj."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib79","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brainres.2005.05.001","article-title":"Morphological alterations produced by zinc deficiency in rat sciatic nerve: a histological, electron microscopic, and stereological study","volume":"1048","author":"Unal","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib80","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1089\/neu.2004.21.1652","article-title":"Functional and morphological assessment of a standardized rat sciatic nerve crush injury with a non-serrated clamp","volume":"21","author":"Varej\u00e3o","year":"2004","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib81","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1179\/016164104225013833","article-title":"Methods for the experimental functional assessment of rat sciatic nerve regeneration","volume":"26","author":"Varej\u00e3o","year":"2004","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2012.06.042","article-title":"Involvement of monoamine oxidase B on models of postoperative and neuropathic pain in mice","volume":"690","author":"Villarinho","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib83","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pnpbp.2013.02.005","article-title":"The antinociceptive effect of reversible monoamine oxidase-A inhibitors in a mouse neuropathic pain model","volume":"44","author":"Villarinho","year":"2013","journal-title":"Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib84","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1586\/14737175.8.5.781","article-title":"Role of central dopamine in pain and analgesia","volume":"8","author":"Wood","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib85","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00702-015-1398-0","article-title":"Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection","volume":"122","author":"Wu","year":"2015","journal-title":"J.\u00a0Neural Transm. (Vienna)"},{"key":"10.1016\/j.neuropharm.2017.10.020_bib86","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1267\/ahc.35.417","article-title":"Monoamine oxidase type B is localized to mitochondrial outer membranes in mast cells, Schwann cells, endothelial cells and fibroblasts of the rat tongue","volume":"35","author":"Xu","year":"2002","journal-title":"Acta Histochem. Cytochem."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib87","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0161-813X(03)00103-7","article-title":"Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation","volume":"25","author":"Youdim","year":"2004","journal-title":"Neurotoxicol"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2017.10.020_bib88","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1038\/sj.bjp.0706464","article-title":"Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness","volume":"147","author":"Youdim","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib89","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib90","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3892\/ijmm.2013.1450","article-title":"Selegiline rescues gait deficits and the loss of dopaminergic neurons in a subacute MPTP mouse model of Parkinson's disease","volume":"32","author":"Zhao","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2017.10.020_bib91","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1111\/j.1471-4159.2008.05330.x","article-title":"Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration","volume":"105","author":"Zhu","year":"2008","journal-title":"J.\u00a0Neurochem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817304872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817304872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T01:14:12Z","timestamp":1603156452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817304872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":90,"alternative-id":["S0028390817304872"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.10.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoamine oxidase-B inhibitor protects degenerating spinal neurons, enhances nerve regeneration and functional recovery in sciatic nerve crush injury model","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}